Tri-GalNAc-DSG-PEG2000
DC68160
View product →
Disclosed in PCT patent WO2025/240833A1 from Acuitas Therapeutics Inc., Compound I‑1 is a trivalent tri-GalNAc PEGylated targeting lipid composed of three ASGPR-binding GalNAc moieties, a PEG spacer and double C18 alkyl lipid tails that insert into LNP lipid bilayer.
| CAS No. | Not available |
| Chemical Name | Galnac Lipid I-1 |
| Synonyms | Not available |
| SMILES | Not available |
| Formula | Not available |
| M.Wt | Not available |
| Purity | >98% |
| Storage | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Shipping condition | Ships from Shanghai; packaging confirmed at order. |
| Publication | Not available |
| Product classification | Galnac Lipids |
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Contact our team with the catalog number and requested quantity.